Cardio IQ® Apolipoprotein B
Test Code
91726
82172
CPT Code is subject to a Medicare Limited Coverage Policy and may require a signed ABN when ordering.
Clinical Significance
Cardio IQ® Apolipoprotein B - Apolipoprotein B (APO B) has been reported to be a powerful indicator of CAD. In some patients with CAD, APO B is elevated even in the presence of normal LDL cholesterol.
Test Resources
Test Summary
Apolipoprotein BTest Summary
Cardiometabolic Disease Assessment (CMDA) PanelTest Summary
Metabolic Risk PanelTest Details
Methodology
Immunoturbidimetric
Reference Range(s)
<90 mg/dL
A desirable treatment target may be <80 mg/dL or lower depending on the risk category of the patient including patients on lipid lowering therapies, patients with ASCVD, diabetes with >1 risk factors, Stage 3 or greater CKD with albuminuria, or heterozygous familial hypercholesterolemia. ApoB relative risk category cut points are based on AACE/ACE and ACC/AHA recommendations (Grundy SM, et al. 2019. doi:10.1016/j.jacc.2018.11.002; Handelsman Y, et al. 2020. doi:10.4158/CS-2020-0490).
| Risk Category | |
| Optimal | <90 mg/dL |
| Moderate | 90-129 mg/dL |
| High | ≥130 mg/dL |
Alternative Name(s)
Apo B,CardioIQ®,ApoB,Apolipoprotein B, Cardio IQ®
Preferred Specimen(s)
1 mL serum
Minimum Volume
0.5 mL
Transport Container
Transport tube
Transport Temperature
Refrigerated (cold packs)
Specimen Stability
- Room temperature: 7 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria
Grossly lipemic
Setup Schedule
1 mL serum
0.5 mL
Transport tube
Refrigerated (cold packs)
Room temperature: 7 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Grossly lipemic